Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling

Journal of Ethnopharmacology

Volumn 133, Issue 1, 2011, Pages 6-13

  Gu, Juan ^a   Wang, Jun Jie ^a,b   Yan, Jin ^a   Cui, Chang Fu ^c   Wu, Wei Hua ^a,d   Li, Ling ^a   Wang, Zhen Shan ^a   Yu, Min ^a   Gao, Na ^a   Liu, Li ^a   Ouyang, Dong Sheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b XIANGNAN UNIVERSITY   (China)

^c Research Institute of China Weapons Industry   (China)

^d HUAIHUA MEDICAL COLLEGE   (China)

Author keywords

Aldose reductase; Captopril; Epalrestat; Eucommia ulmoides; Hypertension; Lignans; Vascular remodeling

Indexed keywords

ALDEHYDE REDUCTASE; CAPTOPRIL; EPALRESTAT; EUCOMMIA ULMOIDES EXTRACT; LIGNAN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DRUG EFFECT; HEART RATE; HEART VENTRICLE REMODELING; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SUPERIOR MESENTERIC ARTERY; WISTAR KYOTO RAT;

ALDEHYDE REDUCTASE; ANIMALS; AORTA; BLOOD PRESSURE; CAPTOPRIL; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; EUCOMMIACEAE; FEMALE; HEART RATE; HYPERTENSION; LIGNANS; MALE; MESENTERIC ARTERY, SUPERIOR; PLANT BARK; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; RATS, WISTAR; RHODANINE; THIAZOLIDINES;

EUCOMMIA ULMOIDES; RATTUS;

EID: 78650679272     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.08.055     Document Type: Article

References (38)

1. A. Bhatnagar, J. Ruef, S. Liu, S. Srivastava, and S.K. Srivastava Regulation of vascular smooth muscle cell growth by aldose reductase Chemico-Biological Interactions 130-132 2001 627 636 (Pubitemid 32295850)
2. D. Barisani, R. Meneveri, E. Ginelli, C. Cassani, and D. Conte Iron overload and gene expression in HepG2 cells: analysis by differential display FEBS Letters 469 2000 208 212
3. Q. Che, T. Jiang, Y.F. Lin, H. Li, and N. Zhang Aldose reductase(AR) gene transfection and AR inhibitors on the proliferation of rat mesangial cells Fudan University Journal of Medical Sciences 32 2005 383 387
4. Chinese Pharmacopoeia Commission Chinese Pharmacopeia 2005 Chemical Industry Publishing House Beijing
5. T. Deyama, S. Nishibe, and Y. Nakazawa Constituents and pharmacological effects of Eucommia and Siberian ginseng Acta Pharmacologica Sinica 22 2001 1057 1070
6. F. Dupuis, J. Atkinson, P. Liminana, and J.M. Chillon Captopril improves cerebrovascular structure and function in old hypertensive rats British Journal of Pharmacology 144 2005 349 356
7. M.D. Evered, and M.M. Robinson Increased or decreased thirst caused by inhibition of angiotensin-converting enzyme in the rat The Journal of physiology 348 1984 573 588
8. C.J. Ge, S.J. Hu, Y.S. Wu, and N.Y. Chen Effects of atorvastin on vascular remodeling in spontaneously hypertensive rats Journal of Zhe Jiang University Science 5 2003 613 615
9. G.H. Gibbons, and V.J. Dzau The emerging concept of vascular remodeling The New England Journal of Medicine 330 1994 1431 1438
10. D.L. Garbers, and S.K. Dubois The molecular basis of hypertension Annual Review Biochemstry 68 1999 127 155
11. K. Grote, I. Flach, M. Luchtefeld, E. Akin, S.M. Holland, H. Drexler, and B. Schieffer Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species Circulation Research 92 2003 e80 e86
12. K.K. Griendling, and M. Ushio-Fukai Reactive oxygen species as mediators of angiotensin II signaling Regulatory Peptides 91 2000 21 27
13. Y.C. Hwang, S. Satoá, J.Y. Tsai, S. Yan, S. Bakr, and H. Zhang Aldose reductase activation is a key component of myocardial response to ischemia The FASEB Journal 16 2002 243 245
14. E.C. Henning, S. Warach, and M. Spatz Hypertension-induced vascular remodeling contributes to reduced cerebral perfusion and the development of spontaneous stroke in aged SHRSP rats Journal of Cerebral Blood Flow & Metabolism 30 2001 827 836
15. M. Inaba, M. Terada, Y. Nishizawa, A. Shioi, E. Ishimura, and S. Otani Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism Metabolism 48 1999 904 909
16. Y.H. Ke, J. Qu, Y.L. Ke, Q.L. Wei, Y.Z. Hu, and D.F. Li Xuyaping reversing vascular remodeling in spontaneous hypertension rats Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease 5 2007 955 958
17. R.J. Keith, P. Haberzettl, E. Vladykovskaya, B.G. Hill, K. Kaiserova, and S. Srivastava Aldose reductase decreases endoplasmic reticulum stress in ischemic hearts Chemico-Biological Interactions 178 2009 242 249
18. N. Liu, X.Q. Chen, H.X. Du, and D.S. Ouyang Separation and purification of the Liganas from Eucommia ulmoides Chemistry 69 2006 302 305
19. L.F. Luo, W.H. Wu, Y.J. Zhou, J. Yan, G.P. Yang, and D.S. Ouyang Antihypertensive effect of Eucommia ulmoides Oliv. extracts in spontaneously hypertensive rats Journal of Ethnopharmacology 129 2010 238 243
20. T. O'Connor, L.S. Ireland, D.J. Harrison, and J.D. Hayes Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members The Biochemical Journal 343 1999 487 504
21. L.M. Ruilope, and E.L. Schiffrin Blood pressure control and benefits of a Antihypertensive therapy: does it make a difference which agents we use? Hypertension 38 2001 537 542
22. K.V. Ramana, D. Chandra, S. Srivastava, A. Bhatnagar, B.B. Aggarwal, and S.K. Srivastava Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells The Journal of Biological Chemistry 277 2002 32063 32070
23. H.L. Rittner, V. Hafner, P.A. Klimiuk, L.I. Szweda, J.J. Goronzy, and C.M. Weyand Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis The Journal of Clinical Investigation 103 1999 1007 10013
24. K.V. Ramana, and S.K. Srivastava Aldose reductase: a novel therapeutic target for inflammatory pathologies The International Journal of Biochemistry & Cell Biology 42 2010 17 20
25. K.V. Ramana, A. Bhatnagar, and S.K. Srivastava Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells The FASEB Journal 18 2004 1209 12018
26. K.V. Ramana, B. Friedrich, S. Srivastava, A. Bhatnagar, and S.K. Srivastava Activation of nuclear factor-KappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase Diabetes 53 2004 2910 2920
27. K.V. Ramana, B. Friedrich, R. Tammali, M.B. West, A. Bhatnagar, and S.K. Srivastava Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells Diabetes 54 2005 818 829
28. K.V. Ramana, A.A. Fadl, R. Tammali, A.B. Reddy, A.K. Chopra, and S.K. Srivastava Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages The Journal of Biological Chemistry 281 2006 33019 33029
29. K.V. Ramana, M.S. Willis, M.D. White, J.W. Horton, J. Michael DiMaio, D. Srivastava, A. Bhatnagar, and S.K. Srivastava Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition Circulation 114 2006 1838 1846
30. E.L. Schiffrin Effects of antihypertensive drugs on vascular remodeling: do they predict outcome in response to antihypertensive therapy? Current Opinion in Nephrology and Hypertension 10 2001 617 624
31. S.K. Srivastava, K.V. Ramana, and A. Bhatnagar Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options Endocrine Reviews 26 2005 380 392
32. S.E. Spycher, S. Tabataba-Vakili, V.B. O'Donnell, L. Palomba, and A. Azzi Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells The FASEB Journal 11 1997 181 188
33. R.M. Touyz, G. Yao, and E.L. Schiffrin c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells Arterioscler Thromb Vasc Biol 23 2003 981 987
34. S. Wassmann, U. Laufs, A.T. Bäumer, K. Müller, C. Konkol, H. Sauer, M. Böhm, and G. Nickenig Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase Molecular Pharmacology 59 2001 646 654
35. Z. Xu, H. Yang, M. Zhou, Y. Feng, and W. Jia Inhibitory effect of total lignans from Fructus Arctii on aldose reductase Phytotherapy Research 24 2010 472 473
36. Y.K. Yao, W.M. Yang, G.F. Yan, and J. Ding Determination of pathological characteristics in spontaneously hypertensive rats Shanghai Laboratory Animal Science 23 2003 75 78
37. J. Yang, C.S. Moravec, M.A. Sussman, N.R. DiPaola, D. Fu, and L. Hawthorn Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays Circulation 102 2000 3026 3027
38. G. Zalba, G. San Jose, M. Moreno, M. Fortuno, A. Fortuno, F. Beaumont, and J. Diez Oxidative stress in arterial hypertension: role of NAD(P)H oxidase Hypertension 38 2001 1395 1399